Crescent Biopharma, Inc. (CBIO)
NASDAQ: CBIO · Real-Time Price · USD
19.98
-1.25 (-5.89%)
At close: May 15, 2026, 4:00 PM EDT
19.97
-0.01 (-0.05%)
After-hours: May 15, 2026, 4:10 PM EDT
Crescent Biopharma Market Cap
Crescent Biopharma has a market cap or net worth of $663.58 million as of May 15, 2026. Its market cap has decreased by -67.27% in one year.
Market Cap
663.58M
Enterprise Value
475.96M
1-Year Change
-67.27%
Ranking
Category
Stock Price
$19.98
Market Cap Chart
Since May 17, 2021, Crescent Biopharma's market cap has decreased from $12.52B to $663.58M, a decrease of -94.70%. That is a compound annual growth rate of -44.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2026 | 607.05M | -43.66% |
| Dec 31, 2025 | 1.08B | -32.93% |
| Dec 31, 2024 | 1.61B | -89.43% |
| Dec 29, 2023 | 15.20B | -5.30% |
| Dec 30, 2022 | 16.05B | 112.95% |
| Dec 31, 2021 | 7.54B | -39.83% |
| May 17, 2021 | 12.52B | - |
View and export this data all the way back to 2021. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bright Minds Biosciences | 763.26M |
| Solid Biosciences | 751.17M |
| Allogene Therapeutics | 738.63M |
| Eikon Therapeutics | 713.55M |
| Tenax Therapeutics | 700.65M |
| Zevra Therapeutics | 689.28M |
| BridgeBio Oncology Therapeutics | 681.08M |
| Aclaris Therapeutics | 670.39M |